| Product Code: ETC12541807 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to rely on imports of liposomal doxorubicin mainly from Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) indicates a market with diverse sources of supply. However, the negative Compound Annual Growth Rate (CAGR) from 2020 to 2024 suggests a declining trend in import volumes. The marginal decrease in growth rate from 2023 to 2024 highlights a relatively stable market environment for liposomal doxorubicin imports into Israel. Monitoring these trends can provide valuable insights for stakeholders in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Liposomal Doxorubicin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Liposomal Doxorubicin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Liposomal Doxorubicin Market - Industry Life Cycle |
3.4 Israel Liposomal Doxorubicin Market - Porter's Five Forces |
3.5 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Liposomal Doxorubicin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Liposomal Doxorubicin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of liposomal doxorubicin for cancer treatment |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with liposomal doxorubicin treatment |
4.3.3 Competition from alternative cancer treatment options |
5 Israel Liposomal Doxorubicin Market Trends |
6 Israel Liposomal Doxorubicin Market, By Types |
6.1 Israel Liposomal Doxorubicin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Doxil, 2021 - 2031F |
6.1.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Lipodox, 2021 - 2031F |
6.1.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Myocet, 2021 - 2031F |
6.1.6 Israel Liposomal Doxorubicin Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Israel Liposomal Doxorubicin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.2.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.2.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Kaposi's Sarcoma, 2021 - 2031F |
6.3 Israel Liposomal Doxorubicin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Israel Liposomal Doxorubicin Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Israel Liposomal Doxorubicin Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Liposomal Doxorubicin Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Israel Liposomal Doxorubicin Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Israel Liposomal Doxorubicin Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel Liposomal Doxorubicin Market Import-Export Trade Statistics |
7.1 Israel Liposomal Doxorubicin Market Export to Major Countries |
7.2 Israel Liposomal Doxorubicin Market Imports from Major Countries |
8 Israel Liposomal Doxorubicin Market Key Performance Indicators |
8.1 Research and development investment in liposomal doxorubicin technology |
8.2 Number of clinical trials involving liposomal doxorubicin in Israel |
8.3 Patient satisfaction and outcomes with liposomal doxorubicin treatment |
8.4 Adoption rate of liposomal doxorubicin by healthcare providers in Israel |
8.5 Rate of adverse events reported with liposomal doxorubicin therapy |
9 Israel Liposomal Doxorubicin Market - Opportunity Assessment |
9.1 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Liposomal Doxorubicin Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Liposomal Doxorubicin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Liposomal Doxorubicin Market - Competitive Landscape |
10.1 Israel Liposomal Doxorubicin Market Revenue Share, By Companies, 2024 |
10.2 Israel Liposomal Doxorubicin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |